Epstein Barr Virus Antibody (15F9) - BSA Free

• Reactivity: V-Vi
• Applications: WB, IHC
• Clone: 15F9
• Clonality: Monoclonal
• Host: Rat
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1.0 mg/ml

Epstein Barr Virus Antibody (15F9) - BSA Free Summary

• Immunogen: Bacterial TrpE-LMP2A fusion protein
• Specificity: Recognizes latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV). EBV is a human herpesvirus, which is associated with conditions such as Hodgkin
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Rat
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 1:10-1:500
  • Western Blot 1:100-1:1000
• Application Notes: This product requires antigen retrieval using heat treatment methods prior to staining of paraffin sections. Sodium citrate buffer pH6.0 is recommended for this purpose.

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS (pH 7.4)
• Preservative: 0.09% Sodium Azide
• Concentration: 1.0 mg/ml
• Purity: Protein G purified

Alternate Names for Epstein Barr Virus Antibody (15F9) - BSA Free

• Epstein Barr Virus
• Human herpesvirus type 4
• Hypothetical protein BALF1

Background

Epstein Barr virus (EBV) is a member of the herpesvirus family and one of the most common human viruses. Most people become infected with EBV during their lives. Primary infections usually results in infectious mononucleosis (glandular fever) but the virus can also lay dormant in B lymphocytes and when reactivated become associated with more serious disease such as Burkitt's lymphoma, nasopharyngeal carcinoma and Hodgkin's disease.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

FAQs for Epstein Barr Virus Antibody (NB100-66574). (Showing 1 - 1 of 1 FAQ).

1. I need the names of the primary and secondary antibodies used in an EBV immunohistochemical method.
   • We have the following primary antibodies for EBV that have been validated in IHC. You would then choose a secondary dependent on the host of the primary you choose - anti-rat or anti-mouse - and conjugated to the label of your choice.